Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.45 (6.87%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £8.36m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

19 Jan 2026 12:15

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, January 19

19 January 2026

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2025 (the “Period”).

Chairman’s Statement

A difficult first half to the Company’s year has been a feature of recent years, with 2025 being no exception, particularly with the SME market being challenging. However, the market started to pick up in November 2025, and there has been a healthy new business pipeline developing in recent months.

During the six months ended 31 October 2025, the Company generated a gross profit of £55,310 (2024: £103,468) and delivered an operating loss of £177,066 (2024: loss of £138,485 ), resulting in an overall loss before tax of £176,515 (2024: loss of £178,261).

The Company’s balance sheet shows a net asset value of £3,063,198 (2024: £3,183,537), representing 2.56p (2024: 3.01p) of value per share in issue. The Board remains positive about the investments that it holds in its client companies, and in particular its core investment in Weardale Lithium.

Whilst there have been delays in completing some advisory projects during the Period, on a positive note, Marechale has in the last few months completed both debt and equity growth round transactions for Wright Brothers, the UK’s leading premium fish wholesaler and restaurant operator, KBH, one of the UK’s leading ‘out of home’ media companies on the UK’s railways and cinemas, Weardale Lithium, which has received planning for the UK’s first Direct Lithium Extraction plant and Chestnut Inns, one of the UK’s leading premium inn operators.

Cash at bank as at 31 October 2025 was £228,593 (2024: £223,700). However, in the months since the end of the Period, and based on the recent transactions that Marechale has completed, the Company has grown its cash at bank to £312,000 as at 14 January 2026.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals.

This plan to continue to develop Marechale’s strategic partnerships in order to enhance shareholder value, and develop new funding partners alongside its traditional investor relationships, has culminated in the successful completion of a placing in Marechale shares in October (as previously announced); this brought in two new strategic investors as well, in addition to all the Company’s directors investing too.

Marechale Capital continues to see interesting corporate finance and advisory projects; the Board believes despite the challenges of the last few years, that the SME market is looking more positive, and that there is a recognition of value in UK growth companies, particularly with new initiatives for the AIM markets, the Enterprise Investment Scheme (EIS), and the move to encourage more private and institutional funding into smaller UK companies.

Whilst the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will continue to be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term, where the Company can generate more value enhancing warrant and founding equity holdings alongside advisory cash fees. The Board is also hoping to agree terms on further strategic partnerships, and is in a number of advanced conversations with different parties.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Income Statement (unaudited)
6 months ended 31 October 2025 2024
£ £
Revenue 111,932 148,500
Cost of sales (56,622) (45,032)
Gross profit 55,310 103,468
Administrative expenses (232,376) (241,953)
Operating loss (177,066) (138,485)
Exceptional credit 600 10,316
Loss on disposal of investments - (49,837)
Interest paid (49) (255)
(Loss) before tax (176,515) (178,261)
Taxation - -
(Loss) after tax (176,515) (178,261)
(Loss) per share
(Pence) (Pence)
- Basic (0.17) (0.17)
- Diluted (0.17) (0.17)

Balance Sheet (unaudited)
As at 31 October 31 October
2025 2024
Current assets
Available for sale investments 2,807,829 2,939,660
Trading investments 58,800 49,953
Trade and other receivables 91,172 52,856
Cash and cash equivalents 228,593 223,712
3,186,394 3,266,181
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(110,811)

(4,885)

(7,500)

(54,338)

(10,806)

(10,000)

Total current liabilities (123,196) (75,144)
Net current assets 3,063,198 3,191,037
Bounce-back Loan – long-term - (7,500)
Net assets 3,063,198 3,183,537
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

955,530

575,790

847,530

481,290

Reserve for own shares (50,254) (50,254)
Retained profits/ (losses) 1,403,817 1,739,397
Reserve for share based payments 178,315 165,574
3,063,198 3,183,537
Cash Flow Statement (unaudited)
6 months ended 31 October 31 October
2024
£
Net cash from operating activities
Loss after tax (176,515) (178,261)
Reverse exceptional credits (600) (10,316)
Loss of disposal of investments - 49,837

Provision for share based payments

Reverse interest paid

-

49

15,406

255

Operating cash flows before movements in working capital (177,066) (123,079)
Movement in working capital
Decrease/ (increase) in receivables 13,852 (7,950)
(Decrease)/ Increase in payables (17,795) 3,108
Net movement in working capital (3,942) (4,842)
Operating cash out-flow (181,009) (127,921)
Investment activities
Expenditure on available for sale investments - -
Proceeds from sale of investments and options - 108,692
Cash flow from investing activities - 108,692

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

202,500

(5,000)

(48)

197,452

-

(5,000)

(255)

(5,255)

Net Increase / (decrease) in cash and cash equivalents 16,443 (24,484)
Cash and cash equivalents at start of the period 212,150 248,196
Cash and cash equivalents at end of the period 228,593 223,712
Increase / (decrease) in cash and cash equivalents 16,443 (24,484)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
2nd Oct 20207:00 amRNSChange of Adviser
28th Sep 20201:20 pmRNSPosting of Annual Report and Notice of AGM
25th Aug 202010:39 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSFinal Results
10th Aug 202010:03 amRNSHolding(s) in Company
7th Aug 20201:05 pmRNSHolding(s) in Company
6th Aug 202010:09 amRNSHolding(s) in Company
5th Aug 202011:35 amRNSHolding(s) in Company
4th Aug 20201:03 pmRNSHolding(s) in Company
30th Jul 20204:40 pmRNSSecond Price Monitoring Extn
30th Jul 20204:35 pmRNSPrice Monitoring Extension
17th Jan 20203:31 pmRNSHolding(s) in Company
12th Dec 20193:08 pmRNSHalf-year Report
24th Sep 201912:16 pmRNSHolding(s) in Company
23rd Sep 20193:38 pmRNSResult of AGM
2nd Sep 20192:46 pmRNSPosting of Annual Report and Notice of AGM
29th Aug 20193:48 pmRNSFinal Results
12th Jul 20191:45 pmRNSBoard Change
1st May 201912:39 pmRNSTrading Statement
25th Jan 201910:16 amRNSInterim Results
12th Dec 20187:00 amRNSChange of Adviser
28th Nov 20185:18 pmRNSChange of Adviser
8th Nov 20183:16 pmRNSDirector/PDMR Shareholding
4th Oct 20182:11 pmRNSResult of AGM
13th Sep 20189:50 amRNSPosting of Annual Report and Notice of AGM
21st Aug 20186:13 pmRNSHolding(s) in Company
21st Aug 201811:35 amRNSFinal Results
5th Jul 20181:55 pmRNSHolding(s) in Company
16th Apr 20182:04 pmRNSHolding(s) in Company
7th Mar 20182:19 pmRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSInterim Results
25th Jan 20182:25 pmRNSHolding(s) in Company
8th Dec 201712:01 pmRNSHolding(s) in Company
9th Nov 20175:01 pmRNSTrading Update
14th Sep 201710:57 amRNSResult of AGM
18th Aug 20173:59 pmRNSPosting of Annual Report and Notice of AGM
14th Aug 201712:20 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSFinal Results
25th Jan 20171:50 pmRNSCapital reduction update
22nd Dec 201611:37 amRNSDirector/PDMR Shareholding
16th Dec 20167:00 amRNSHalf-year Report
15th Sep 20161:13 pmRNSDirector/PDMR Shareholding
14th Sep 201612:54 pmRNSResult of AGM
24th Aug 20164:36 pmRNSPosting of Annual Report & Notice of AGM
25th Jul 20167:00 amRNSFinal Results
4th May 201611:42 amRNSStmnt re Share Price Movement
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.